Enter your email address
Submit
Write your message
Volume 16, Issue 4 (Iranian Journal of Breast Diseases 2024)
ijbd 2024, 16(4): 98-115 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khezrian A, Shojaeian A. Role of the Stromal Vascular Fraction in Breast Reconstruction after Breast Cancer Surgery: A Review. ijbd 2024; 16 (4) :98-115
URL: http://ijbd.ir/article-1-1050-en.html
URL: http://ijbd.ir/article-1-1050-en.html
Role of the Stromal Vascular Fraction in Breast Reconstruction after Breast Cancer Surgery: A Review
1- Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2- Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran ,ali.shojaeian65@gmail.com
2- Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran ,
Abstract: (730 Views)
Introduction: Breast cancer is among the main reasons for most cancer-associated loss of life in women worldwide. The use of autologous lipotransfer has become increasingly popular for breast reconstruction. With the emerging data on the efficacy of stromal vascular fraction (SVF) in oncological safety and survival rates, although many studies have focused on improving the preservation of fat graft volume with this material, questions regarding safety and efficacy still remain. The present study aimed to determine the advantages and disadvantages of SVF in fat grafting, especially in its preservation.
Materials and Methods: Our search was conducted on published research between 2000 and 2022 using several international databases, including Scopus, PubMed, Web of Science, and Google Scholar. We also reviewed additional evidence from relevant published articles.
Results: Although the SVF is easier to isolate than adipose-derived mesenchymal stem cells (ADSCs), it contains a heterogeneous mix of cells. The SVF may act through angiogenesis promotion by endothelial/progenitor cells and immunomodulation by ADSCs. The SVF-enhanced fat grafts improve volume retention in animal models. Although limited clinical data supports improved breast augmentation with SVF without increased cancer recurrence, optimal SVF isolation and cell ratios require further research.
Conclusion: Based on the obtained findings, although SVF shows promise to improve fat grafting outcomes in breast reconstruction, more clinical studies on oncologic safety and technical considerations are warranted.
Materials and Methods: Our search was conducted on published research between 2000 and 2022 using several international databases, including Scopus, PubMed, Web of Science, and Google Scholar. We also reviewed additional evidence from relevant published articles.
Results: Although the SVF is easier to isolate than adipose-derived mesenchymal stem cells (ADSCs), it contains a heterogeneous mix of cells. The SVF may act through angiogenesis promotion by endothelial/progenitor cells and immunomodulation by ADSCs. The SVF-enhanced fat grafts improve volume retention in animal models. Although limited clinical data supports improved breast augmentation with SVF without increased cancer recurrence, optimal SVF isolation and cell ratios require further research.
Conclusion: Based on the obtained findings, although SVF shows promise to improve fat grafting outcomes in breast reconstruction, more clinical studies on oncologic safety and technical considerations are warranted.
Keywords: Adipose-derived stem/progenitor cells, Breast cancer, Breast reconstruction, Regenerative medicine, Stromal Vascular Fraction
Type of Study: review |
Subject:
Diagnosis, treatment, rehabilitation
Received: 2023/05/30 | Accepted: 2023/11/29 | Published: 2024/01/7
Received: 2023/05/30 | Accepted: 2023/11/29 | Published: 2024/01/7
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
